Working with mental health advocates and Mental Health America, the “Generation Fine” project “highlights the unique ...

ALTO-207 is a fixed-dose combination of pramipexole, a dopamine D3/D2 agonist with antidepressant activity demonstrated across multiple prior studies, and ondansetron, a 5-HT3 antagonist anti-emetic.

A meta-analysis of studies involving over 3.2 million participants found that major depressive disorder is significantly more ...

Researchers discover a paradox: high cognitive performance predicts depressive relapse, contradicting traditional expectations.

What social risk factors affecting your patients may affect their risk of major depressive disorder more than they realize?

Treatment with oral semaglutide (Rybelsus) significantly improved motivation measures in patients with major depressive ...

The use of 42 mg lumateperone combined with antidepressant therapy was linked to significantly reduced severity of depression and anxiety, as well as greater response and remission rates, and was ...

Before your first psychiatrist appointment for major depressive disorder, you can do many things to prepare. By planning ahead, you’re doing everything on your end to make sure you have a smooth ...

A new meta-analysis of 55 studies involving more than 3 million people has found that 31% of individuals with cannabis use ...